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Abstract
Amino acids are fundamental nutrients for protein synthesis and cell growth (increase in cell size). Recently, many compelling evidences have
shown that the level of amino acids is sensed by extra- or intra-cellular amino acids sensor(s) and regulates protein synthesis/degradation. Mammalian
target of rapamycin complex 1 (mTORC1) is placed in a central position in cell growth regulation and dysregulation of mTOR signaling pathway
has been implicated in many serious human diseases including cancer, diabetes, and tissue hypertrophy. Although amino acids are the most potent
activator of mTORC1, how amino acids activate mTOR signaling pathway is still largely unknown. This is partly because of the diversity of amino
acids themselves including structure and metabolism. In this review, current proposed amino acid sensing mechanisms to regulate mTORC1 and 
the evidences pro/against the proposed models are discussed. 
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Rapamycin, an antifungal macrolide purified from Streptomyces 
hygroscopicus (Abraham & Wiederrecht, 1996) has potent 
immunosuppressant and antiproliferative properties and currently 
is used as a FDA-approved immunosuppressant and anticancer 
drug. Its cellular target was identified from yeast genetic screening 
in which mutation of TOR1-1 and TOR2-1 genes showed resistance 
to the growth-inhibitory properties of rapamycin (Heitman et al., 
1991). TOR homologs have also been identified in plants (AtTOR 
in Arabidopsis thaliana) (Menand et al., 2002), fungus (TOR1 
in Cryptcococcus neoformans) (Cruz et al., 1999), Caenorhabditis 
elegans (CeTOR) (Hara et al., 2002), Drosophila (dTOR) (Oldham 
et al., 2000; Zhang et al., 2003), and mammals (mTOR) (Brown 
et al., 1994; Chiu et al., 1994; Sabatini et al., 1994). Unlike 
yeast TOR1 and TOR2, however, mammals have only one TOR 
gene.
TOR is a serine/threonine protein kinase and a member of 
phosphatidylinositol kinase-related kinase (PIKK) family 
(Schmelzle & Hall, 2000). It consists of 20 tandem HEAT repeats 
at the N-terminal followed by an FAT and FRB (FKBP12/ 
rapamycin binding) domains. mTOR kinase domain is located 
in between FRB and FATC (FAT C-terminus) domain at the 
C-terminus of the protein (Inoki et al., 2005a). Rapamycin binds 
with immunophilin FKBP12 (FK506-binding protein 12 kDa) in 
the cell and forms a complex (Abraham & Wiederrecht, 1996). 
It appears that this FKBP12-rapamycin complex binds to FRB 
domain and inhibits physiological functions of mTOR, however, 
exact mechanism has not been elucidated yet. mTOR exists in 
two distinct protein complexes, mTOR complex1 (mTORC1) and 
mTOR complex2 (mTORC2) (Hara et al., 2002; Kim et al., 2002; 
Jacinto et al., 2004; Sarbassov et al., 2004). mTORC1 consists 
of mTOR, Raptor, mLST8 (GβL), PRAS40 (proline-rich Akt/PKB 
substrate 40 kDa), and recently identified FKBP38 (Bai et al., 
2007; Yang & Guan, 2007). mTORC1 regulates the rate of protein 
synthesis and cell growth in a rapamycin sensitive way (Fig. 1) 
(Fingar et al., 2002; Hay & Sonenberg, 2004). While in mTORC2, 
mTOR interacts with Rictor, mLST8, Protor (protein observed 
with Rictor) (Pearce et al., 2007), and mSin1 (reviewed in (Yang 
& Guan, 2007)). Unlike mTORC1, mTORC2 activity is not 
inhibited by rapamycin at least in a short time period (Jacinto 
et al., 2004; Sarbassov et al., 2004). Substrates of mTORC2 include 
Akt and SGK (serum and glucocorticoid-inducible kinase) 
(Garcia-Martinez & Alessi, 2008). mTORC2 also regulates 
maturation and stability of conventional PKC (Facchinetti et al., 
2008; Ikenoue et al., 2008) and has known to be involved in 
cytoskeletal organization (Loewith et al., 2002; Jacinto et al., 
2004). mTORC2 is activated by growth factors such as insulin 
but not by nutrients. 
Raptor is a scaffold protein which recruits substrates to mTOR 
and knock-down of Raptor abolishes physiological activity of 
mTOR (Hara et al., 2002; Kim et al., 2002). mLST8 binds to 
mTOR kinase domain and activates the kinase activity 
independent of Raptor (Kim et al., 2003). Recent in vivo studies 
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Fig. 1. Regulation of mTORC1 mTORC1 is a multiprotein complex composed of 
Raptor,  mLST8,  PRAS40,  and  FKBP38  and  regulates  protein  synthesi s  a n d  c e l l  
g r o w t h  b y  p h o s p h o r y l a t i n g  S 6 K 1  a n d  4 E B P 1 .  R h e b  d i r e c t l y  b i n d s  a nd  activates 
mTOR kinase. GTP-bound active Rheb sequesters FKBP38 which otherwise binds 
and inhibits mTORC1. TSC1/2 heterodimer converts Rheb from GTP-bound active 
to  GDP-bound  inactive  form.  In  Drosophila,  TCTP  was  identified  as  Rheb  GEF. 
mTORC1  activity  is  precisely  coordinated  by  growth  factors  such  as  insulin  or 
insulin-like growth factor and nutrients. Insulin binding to insulin receptor recruits IRS
and  subsequently  activates  PI3K  and  PDK1.  PDK1  then  phosphorylates  and 
activates  Akt  which  in  turn  phosphorylates  two  negative  regulators  of  mTORC1, 
TS C 2  an d  P R A S 4 0, and  relieves th eir inh ib itory fun ctio n . A m ino  acids  stimulation 
does not phosphorylate Akt, however, strongly phosphorylates S6K and 4EBP1 in 
the  absence  of  insulin  stimulation.  Recently  three  proteins,  Rag,  Vps34,  and 
MAP4K3, have been presented as putative intracellular amino acid sensors. Each 
protein activates mTORC1 by distinctive mechanism. On the other hand, activated 
S6K1  phosphorylates and  degrades IRS by negative feedback  inhibition which in 
turn inhibits PI3K and mTORC1 signaling pathway (for details, see text). IRS: insulin 
receptor  substrate;  PI3K:  phosphatidylinositol  3  phosphate  kinase;  PDK1: 
3-phosphoinositide-dependent  protein  kinase1;  Note:  uncertain  pathway  is 
delineated  as  dashed  line.
using mLST8-/- MEFs (mouse embryonic fibroblasts), however, 
showed that an ability of mTOR to phosphorylate its substrates, 
S6K and 4EBP1, and to interact with Raptor was not impaired 
in these cells (Guertin et al., 2006), which suggests that mLST8 
may not be an indispensable component of mTORC1 function. 
PRAS40 acts as a negative regulator of mTORC1 either by 
binding directly to the mTOR kinase domain and inhibits kinase 
activity (Vander Haar et al., 2007) or by association with Raptor 
via a TOR signaling motif (TOS motif) in PRAS40, which can 
cause substrate competition to Raptor (Oshiro et al., 2007; 
Sancak  et al., 2007; Wang et al., 2007). On the other hand, 
insulin stimulation phosphorylates Thr246 site of PRAS40 and 
relieves its inhibitory effect on mTORC1, which suggests that 
PRAS40 mediates growth factor signals to mTORC1. Bai et al. 
(2007) identified that FKBP38 also acts as a negative regulator 
of mTORC1 and overexpression of FKBP38 inhibits S6K1 
(T389), S6 (S235/236), and 4EBP1 (T37/46) phosphorylation.
The best-characterized protein substrates of mTORC1 are 
S6K1 and 4EBP1. mTORC1 recruits and phosphorylates S6K1 
and 4EBP1 via interaction of Raptor and TOS motif located at 
the N-terminus and C-terminus of S6K1 and 4EBP1, respectively 
(reviewed in (Fingar et al., 2002; Hay & Sonenberg, 2004)). 
Activated S6K1 phosphorylates 40S ribosomal protein S6, which 
has been suggested to selectively increase the translation of 
subset of mRNAs containing a terminal oligopyrimidine (TOP) 
tract at their 5’-end. Since many of the 5’TOP mRNAs encode 
ribosomal proteins and other translation factors, activated S6K 
by mTOR is thought to increase ribosome biogenesis. 4EBP1 
is a translational repressor. Its unphosphorylated form binds and 
inhibits eukaryotic translation initiation factor 4E (eIF4E) which 
binds to the Cap structure (m
7GpppN) at the 5’-end of mRNA 
transcripts. Phosphorylation of 4EBP1 by mTOR dissociates tight 
4EBP1 binding from eIF4E from which eIF4E recruits other 
components of the translation initiation complex and initiates 
cap-dependent translation, which increases overall translational 
capacity of the cell. S6K1 also phosphorylates translation 
inactivating kinase, eukaryotic elongation factor2 (eEF2) kinase, 
and inactivates its function (Redpath et al., 1996). mTOR 
activation, therefore, promotes elongation process as well. 
The activity of mTORC1 is finely tuned by upstream positive 
and negative regulators (Hay & Sonenberg, 2004). Rheb 
(Ras-homolog enriched in brain) small GTPase is a positive 
regulator of mTORC1 and is indispensable for mTOR activity. 
It directly binds to the carboxyterminal lobe of the mTOR 
catalytic domain and modulates the kinase activity (Long et al., 
2005a; Sancak et  al., 2007). S6K1 and 4EBP1 can not be 
phosphorylated if Rheb gene is knocked down (Zhang et al., 
2003), whereas, overexpression of Rheb stimulates S6K1 and 
4EBP1 phosphorylation (Inoki et al., 2003a; Tee et al., 2003). 
TSC (tuberous sclerosis complex) 1 and 2 heterodimer acts as 
Rheb GAP (GTPase activation protein) and converts Rheb to 
GDP-bound inactive form (Garami et al., 2003; Inoki et al., 
2003a; Tee et al., 2003). TSC1/2 integrates a variety of signals 
including insulin, growth factors, and energy status and 
negatively regulates mTORC1 (Inoki et al., 2003b). Recently, 
Drosophila TCTP (translationally controlled tumour protein) has 
been reported as dRheb GEF (GTPase exchange factor) and 
activates dTOR (Hsu et al., 2007). Whether mammalian TCTP 
also can act as Rheb GEF or not needs to be examined.
Mechanisms of amino acid sensing
The first indication that amino acids are involved in mTORC1 
pathway was shown in the study of hepatocyte autophagy 
(Blommaart  et al., 1995) in which cellular organelles are 
encompassed by intracellular double membrane followed by 
formation of autophagosome-lysosome complex and degraded 
(Shitani & Klionsky, 2004). In the study, addition of amino acids 
inhibited valine release as a result of autophagic protein 
degradation in the cell and this inhibition was sharply correlated 
with the increase of S6 phosphorylation. Moreover, the effects 
of the amino acids were inhibited by rapamycin. Then the 
question is how the level of amino acids is sensed and signals 
to mTORC1 (Fig. 2).66 Amino acid sensing mechanism
Fig. 2. Current proposed mechanisms of amino acid sensing by mTORC1 
A m i n o  a c i d s  a r e  i m p o r t e d  i n t o  t h e  c e l l s  v i a  v a r i o u s  a m i n o  a c i d  transporters  and 
activate  mTORC1  either  by  amino  acid  metabolites  or  by  undefined 
membrane/intracellular amino acid sensor(s). Figure depicts a case of L-leucine (for 
details,  see  text).  AT:  aminotransferase;  α-KIC:  α-ketoisocaproic  acid;  BCKDH: 
branched-chain  α-ketoacid  dehydrogenase;  GDH:  glutamate  dehydrogenase; 
AOAA:  aminooxyacetic  acid
Amino acid sensing on the cell membrane
Amino acids are imported to the cells via various amino acid 
transporters on the cell membrane. Miotto et al. (1992; 1994) 
tested the hypothesis whether amino acid signaling is initiated 
from the membrane transporter using nontransportable peptide 
Leu8-MAP which contains eight leucine (the single most effective 
amino acid) residues outside and a leucine analogue, Isovaleryl- 
L-Carnitine (IVC). Treatment of isolated rat hepatocytes with 
these compounds inhibited macroautophagy and proteolysis, 
which indicates that Leu8-MAP, IVC, and probably free leucine 
must be recognized at the plasma membrane or within an 
associated vacuole. Different group, however, reported that only 
after over 1 hour treatment of the Leu8-MAP could phosphorylate 
S6 in some degree and moreover, in rat adipocytes, S6K1 and 
4EBP1 phosphorylation was unresponsive to Leu8-MAP or IVC 
(Lynch et al., 2000). Another concern on this hypothesis is that 
amino acid transporter systems have low specificity or strictness 
in the kind of amino acids or in structural requirement (Hyde 
et al., 2003). For example, system L amino acid transporter can 
import isoleucine, valine, methionine, phenylalanine, and 
histidine to the cells other than leucine. Conversely, pretreatment 
of 2-amino-3-norbane carboxylic acid (BCH), a selective system 
L amino acid transporter inhibitor, did not inhibit leucine-induced 
mTORC1 activity because leucine could be imported through 
other transporter system (Lynch et al., 2000). On the other hand, 
it has been suggested that amino acids-induced cell swelling is 
a mechanism of amino acids-mediated mTORC1 activation. 
Some amino acids are transported into the cell via Na+-dependent 
transporters from which intracellular osmolarity is increased due 
to imported Na+ and accumulated amino acid metabolites (Hyde 
et al., 2003). Cell swelling itself has shown to exert similar 
effects as insulin in which protein synthesis is stimulated and 
protein degradation is inhibited (reviewed in (Haussinger, 1996)). 
So far, however, how cell swelling regulates these processes is 
not known. Moreover, the most effective leucine transporter, 
system L amino acid transporter, is Na+-independent. This 
suggests that intracellular amino acid concentration or 
intracellular receptor, but not a particular membrane amino acid 
transporter, is responsible for the regulation of mTORC1 
signaling pathway. 
Amino acid sensing by aminoacyl tRNA formation
Bacteria and yeast recognize amino acids starvation by 
increased concentration of deacylated tRNA or reduced availability 
of aminoacylated tRNA. In Jurkat cells, amino acid alcohols 
which compete with amino acids prevent aminoacyl-tRNA 
formation and inhibit S6K1 phosphorylation (Iiboshi et al., 1999). 
Inhibition of protein synthesis by applying translation inhibitors 
such as cycloheximide (CHX) and puromycin has shown to 
increase S6K1 phosphorylation in the amino acids starvation 
condition (Iiboshi et al., 1999). These data suggest that increased 
level of intracellular amino acids resulted from translation 
inhibition and of aminoacylated tRNA is responsible for the 
amino acid sensing in mammalian cells as well. However, this 
is not consistent with time frame in which mTORC1 is activated. 
The level of intracellular amino acids is not changed during short 
time (30 min) amino acids starvation or stimulation, whereas, 
S6K1 phosphorylation is changed within this short time frame. 
Moreover, in rat adipocytes, leucine alcohol (leucinol) treatment 
did not affect 4EBP1 phosphorylation (Lynch et al., 2000). On 
the other hand, it appears that Rheb and TOR are not involved 
in nutrient import. Suppression of Rheb and TOR gene expression 
by RNAi in Drosophila S2 cells did not affect nutrients (glucose 
& bulk amino acids) import but significantly reduced ribosome 
biogenesis, protein synthesis, and cell size (Hall et al., 2007). 
Taken together, these data raise a question on this hypothetical 
mechanism as well. 
Amino acid sensing by amino acid metabolites
Imported amino acids are subjected for amino acid metabolism 
and there are several reports suggesting that amino acid 
metabolites including ATP are responsible for mTORC1 
activation. For example, leucine is metabolized to α-ketoisocaproic 
acid (α-KIC) by reversible aminotransferase (AT), which is then 
further metabolized to TCA cycle intermediates by branched- 
chain  α-ketoacid dehydrogenase (BCKDH). Otherwise, leucine 
as it is can be an allosteric activator of glutamate metabolizing 
enzyme, glutamate dehydrogenase (GDH) (Fahien et al., 1988; 
Sener & Malaisse, 1980). The consequence of leucine metabolic 
pathways would be production of ATP and other metabolically- 
linked secondary signals, which was proposed as a mechanism 
of mTOR signaling pathway activation by leucine in pancreatic 
β-cells (McDaniel et al., 2002). In fact, Dennis et al. (2001) 
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sensor and ATP depletion caused by incubation of cells with 
2-deoxyglucose or several mitochondria inhibitors including 
rotenone and antimycin A inhibits S6K1 and 4EBP1 phosphorylation 
(Inoki  et al., 2003b; Xu et al., 2001). A concern on this 
hypothesis is that the concentration of ATP is not affected by 
short time amino acids deprivation or stimulation in most 
mammalian cells (Dennis et al., 2001). Nevertheless, it has been 
shown that an AT inhibitor, aminooxyacetic acid (AOAA), 
inhibits S6K1 phosphorylation upon leucine treatment in 
pancreatic β-cells (Xu et al., 2001). A nonmetabolized leucine 
analog, β (±) 2-aminobicyclo [2.2.1] heptane-2-carboxylic acid, 
also failed to stimulate S6K1 phosphorylation in the absence of 
leucine (McDaniel et al., 2002). Moreover, proteolytic dose 
responses and inhibition of autophagy to L-leucine and to IVC, 
readily metabolizable leucine analogue, were similar in the 
perfused rat liver (Miotto et al., 1992). Stimulation with α-KIC 
phosphorylates 4EBP1 in the absence of leucine in adipocytes 
(Lynch et al., 2000). Taken together, this suggests that although 
it is difficult to pinpoint exactly what it is, certain products of 
leucine oxidation are responsible for mTORC1 activation.
In the liver, however, leucine is poorly metabolized owing to 
its low rate of transamination. Therefore, we still can not exclude 
a possibility that the effect of leucine on the mTORC1 activation 
is due to leucine itself at some undefined locus of recognition. 
Leucine metabolizing enzyme, AT, is a reversible aminotransferase 
which also can convert α-KIC to leucine. Interestingly, α-KIC 
induced phosphorylation of 4EBP1 was less than leucine induced 
4EBP1 phosphorylation and moreover, α-KIC effect was 
attenuated in the presence of transaminase inhibitor, L-cycloserine 
(Lynch  et al., 2000). Lynch et al. (2000) also found that 
norleucine which is not incorporated in protein translation was 
as effective as leucine in 4EBP1 phosphorylation, which suggests 
that there may be a specific intracellular leucine receptor, which 
recognizes the specific structure of leucine. However, leucine 
analogues which contain either strong leucine agonist or 
antagonist activity in one cell line do not always exert the same 
effect in different cell lines. Therefore, this proposed mechanism 
can be cell-type specific. 
Amino acid sensing by mTORC1 
Although the mechanism is not known, it is obvious that amino 
acids regulate mTORC1 activity (Hara et al., 1998). That is, amino 
acids stimulation increases S6K1 and 4EBP1 phosphorylation, 
whereas, amino acids deprivation rapidly dephosphorylates S6K1 
and 4EBP1. Therefore, extensive research efforts have centered 
on mTORC1 regulation itself.
Ectopic overexpression of Rheb completely inhibited S6K1 and 
4EBP1 dephosphorylation upon amino acids withdrawal (Long 
et al., 2005a; 2005b; Saucedo et al., 2003). Since Rheb activates 
mTORC1 activity by directly binding to mTOR, Rheb-mTOR 
interaction was examined. Long et al. (2005b) showed that 
Rheb-mTOR interaction was in fact reduced upon amino acids 
withdrawal, whereas the interaction was fully recovered when 
amino acids alone were added to D-PBS. Amino acids, however, 
did not change Rheb-Raptor and Rheb-mLST8 interaction (Long 
et al., 2005b). Curiously, however, Rheb-mTOR interaction is 
not affected by nucleotide binding status of Rheb (Long et al., 
2005a). The binding of nucleotide-free mutant of Rheb to mTOR 
was even stronger than that of wild-type Rheb, although it 
impaired mTOR kinase activity. Amino acids modulation of 
nucleotide binding status of Rheb is also not in consistency. For 
example, GTP level of overexpressing Rheb was increased by 
amino acids stimulation (Smith et al., 2005), but endogenous 
Rheb-GTP charging was not changed by amino acids withdrawal 
(Nobukuni et al., 2005). Roccio et al. (2006) reported that amino 
acids starvation did not change Rheb-GTP level, but add back 
amino acids clearly increased Rheb-GTP loading. In consistent 
with this, TSC1/2 is also not required for amino acids-mediated 
mTORC1 regulation (Roccio et al., 2006; Smith et al., 2005). 
Amino acids withdrawal still dephosphorylated S6K1 and 4EBP1 
independent of TSC2 gene expression (Nobukuni et al., 2005; 
Smith  et al., 2005). On the other hand, it has been proposed 
that amino acids regulate mTORC1 activity by modulating 
mTOR-Raptor interaction. Amino acids starvation causes tighter 
binding of Raptor to mTOR which inhibits mTOR kinase activity 
whereas amino acids stimulation loosens the interaction (Kim 
et al., 2002). The mLST8-mTOR interaction was not affected 
by amino acids. This suggests that amino acids specifically 
modulate mTOR-Raptor interaction and regulate mTOR kinase 
activity.
Amino acid sensing by intracellular proteins
Recently, several intracellular proteins have been identified as 
intracellular amino acid sensors which include hVps34, 
MAP4K3, and Rag.
Vps34: Vps34 is a Class III PI3K which forms an active 
complex with another kinase Vps15 and generates PtdIns(3)P by 
phosphorylating the 3’ hydroxyl position of the phosphatidylinositol 
ring (reviewed in (Backer, 2008; Nobukuni et al., 2007; Yan 
& Backer, 2007)). Vps34 was initially known to play an 
important role in vesicular trafficking (Lindmo & Stenmark, 
2006; Odorizzi et al., 2000) and a role of Vps34 in amino acids 
sensing has been recently reported (Byfield et al., 2005; 
Nobukuni  et al., 2005). That is, hVps34 activity as well as 
PtdIns(3)P production was increased by amino acids stimulation. 
On the contrary, suppression of hVps34 gene expression with 
hVps34 siRNA or overexpression of GFP-FYVE (Fab1p, YOTB, 
Vac1p, EEA1 (early endosomal antigen 1)) expression vector 
which acts as a dominant negative by sequestering PtdIns(3)P 
impaired S6K1 and 4EBP1 phosphorylation but did not affect 
insulin-stimulated Akt phosphorylation. It appears that, however, 
amino acids do not directly regulate hVps34 activity. Instead, 
amino acids stimulation facilitates Ca
2+ influx, which in turn 
increases the interaction of Ca
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and activates mTORC1 (Gulati et al., 2008). There are several 
concerns, however, on presenting hVps34 as an amino acids 
sensing system to activate mTORC1. Ectopic expression of 
hVps34 to mammalian cells increased S6K phosphorylation only 
in the presence, but not in the absence of amino acids (Nobukuni 
et al., 2005). In the study of Yan et al. (2009) hVps34 activity 
was not affected by Ca
2+ chelators or CaM inhibitors. Most of 
all, in a recent Drosophila in vivo study, loss-of-function mutant 
animals of Drosophila Vps34 showed disrupted autophagy and 
endocytosis but TOR signaling was not affected by disruption 
of Vps34 gene (Juhasz et al., 2008). That is, cell size was similar 
between Vps34 mutant and wild-type cells and moreover, 
modulation of cell size by overexpressing Rheb (increased cell 
size) or TSC1/2 (decreased cell size) was not affected by Vps34 
mutation. Nevertheless, amino acids starvation induced 
autophagy in control animals but not in Vps34 mutant animals. 
Considering that reported function of hVps34 in amino acid 
signaling has been all performed in cell culture system, this 
observation in vivo raises a significant question on the proposed 
model.
MAP4K3: Findlay et al. (2007) identified MAP4K3 protein 
kinase as an important intracellular protein in amino acids 
sensing. They showed MAP4K3 kinase activity was regulated 
by amino acids and overexpression of MAP4K3 specifically 
increases S6K phosphorylation even in the amino acids starvation 
condition in a TSC1/2 independent manner. This is a difference 
between hVps34 and MAP4K3 in amino acids sensing since 
ectopic expression of hVps34 increases S6K1 phosphorylation 
only in the presence of amino acids. Nevertheless, it would be 
interesting to address a question whether overexpression of 
MAP4K3 increases PtdIns(3)P either in the presence or absence 
of amino acids.
Rag: Most recently, two independent research groups newly 
discovered that Rag (Ras-related GTPases) small GTPases 
(RagA, B, C, and D) play an important role in amino acid 
signaling (Kim et al., 2008; Kim & Guan, 2009; Sancak et al., 
2008). 
In Drosophila S2 cells, knock-down of dRag gene expression 
impaired dS6K phosphorylation upon amino acids stimulation 
(Kim et al., 2008). In mammalian cells, expression of GTP-bound 
active RagA
QL/RagB
QL overcomes S6K1 dephosphorylation in 
amino acids deprivation condition, whereas GDP-bound inactive 
RagA
TN/B
TN inhibited S6K1 phosphorylation upon amino acids 
stimulation. Moreover, dRagA
QL expressing cells showed bigger 
cell size than neighboring wild type cells and inhibited 
starvation-induced autophagy in Drosophila. Sancak et al. (2008) 
identified RagC as a Raptor interacting protein using a 
purification method. Amino acids increase GTP-level of RagB 
and RagB
QL-RagC
SN heterodimer increases mTORC1 activity by 
increasing Raptor-mTOR interaction. On the other hand, in 
RagB
QL expressing cells, mTOR was already present on the Rab7 
positive peri-nuclear and vesicular structures even in the amino 
acids deprivation condition. Interestingly, hVps34 and hVps15 
also co-localize to Rab7-positive late endosome. This suggests 
that the function of Rag, mTOR, and hVps34 can be 
interconnected on Rab7 positive endosome membrane and may 
involve in amino acids transporter trafficking to the cell 
membrane as yeast Rag homologue, Gtr does (Gao et al., 2006). 
Recently, Nicklin et al. (2009) found that L-glutamine uptake 
by solute carrier family1 (SLC1A5) transporter is important for 
L-leucine/essential amino acids (EAA) import into the cells. 
Simultaneous efflux of L-glutamine out of cells through 
SLC7A5/SLC3A2, a bidirectional transporter, facilitates L-leucine/ 
EAA import into the cells from which mTORC1 is activated. 
In contrast to L-glutamine, L-glutamic acid and α-ketoglutarate 
pretreatment could not activate S6K1 upon EAA treatment, which 
suggests that L-glutamine effect on S6K1 is not due to increasing 
cellular energy level. Interestingly, previously performed large- 
scale genetic array analysis identified that protein mutations 
involved in glutamate/glutamine homeostasis also genetically 
interact with Gtr2 (Dubouloz et al., 2005). Lethal phenotype of 
these mutants was reversed either by glutamate supplement in 
the medium or by introduction of Gtr2-expression plasmids. 
Moreover, Gtr2 mutant suppressors identified from genome-wide 
screen include genes which are directly or indirectly involved 
in glutamate/glutamine synthesis/degradation. It has been shown 
that Gse complex consisted of five proteins encoded by Gtr1, 
Gtr2, YBR077C (EGO3), YKR007W (EGO1), and LTV1 genes 
plays an important role in recycling of general amino acid 
permease, Gap1p, from the late endosome to the plasma 
membrane in yeast (Gao et al., 2006). Therefore, it will be 
interesting to address a question whether Rag affect SLC1A5 
and SLC7A5/SLC3A2 transporter trafficking and whether 
imported L-leucine/EAA activates mTORC1 through Rag.
Concluding remarks
How amino acids regulate protein synthesis and cell growth 
has been a fundamental biological question in the field. Since 
inhibition of TOR pathway mimics amino acids starvation 
condition and moreover, amino acids are the most potent activator 
of TOR, extensive research efforts have centered on elucidating 
a mechanism of amino acids sensing in mTOR signaling pathway. 
From the cell membrane to intracellular proteins, each path of 
amino acids has been examined for a possible amino acid sensing 
point, however, there have been still many controversies in 
experimental data due to such a structural and metabolic diversity 
of amino acids. Recent identification of hVps34, MAP4K3, and 
Rag GTPases as important intracellular proteins in amino acid 
signaling and of a mechanism of L-Leucine/EAA import into 
the cells made a significant progress in our understanding of 
amino acids-mediated mTOR activation. However, how imported 
amino acids are sensed by hVps34, MAP4K3, or Rag GTPases 
and activate mTORC1 still remains as an open question. The 
importance of understanding amino acid signaling is that it has Eunjung Kim 69
many significant physiological and pathological implications in 
vivo. Anabolic response of the body after protein meal ingestion 
is closely correlated with phosphorylation of S6K1 and 4EBP1 
in mice, rat, and human (Balage et al., 2001; Long et al., 2000; 
Shah  et al., 2000). Insulin production in pancreatic β-cells is 
increased by amino acids stimulation (May & Buse, 1989) and 
amino acids infusion increases the sensitivity of muscle protein 
synthesis to insulin (Garlick & Grant, 1988). Furthermore, 
activated S6K in turn phosphorylates and degrades insulin 
receptor substrate (IRS) and inhibits PI3K signaling pathway as 
a negative feedback inhibition, which can decrease insulin 
sensitivity and lead to diabetes (Fig. 1). Overactivated mTORC1 
signaling pathway is frequently found in various cancers and 
tissue/organ hypertrophy as well (Guertin & Sabatini, 2007; Inoki 
et al., 2005b; Lee et al., 2007). Although rapamycin has been 
used as an FDA-approved drug to treat some of the cancers 
including sarcoma, suppression of S6K phosphorylation can 
result in activating PI3K signaling which can further exacerbate 
the disease state. Therefore, if we elucidate a mechanism on the 
amino acid signaling pathway to mTORC1 activation, more 
specific and effective way to prevent or treat these diseases can 
be developed.
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